| Identification | |
| Name: | Tamsulosin hydrochloride |
| Synonyms: | Benzenesulfonamide,5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-,monohydrochloride (9CI);Benzenesulfonamide,5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, monohydrochloride,(R)-;(-)-YM 12617;(R)-(-)-YM 12617;Flomax;Harnal;LY 253351;Omic;Omnic;YM 12617-1;YM 617;Yutanal;Tamsulosin HCl; |
| CAS: | 106463-17-6 |
| Molecular Formula: | C20H29ClN2O5S |
| Molecular Weight: | 444.97 |
| InChI: | InChI=1/C20H28N2O5S.ClH/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24;/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24);1H/t15-;/m1./s1 |
| Molecular Structure: | ![(C20H29ClN2O5S) Benzenesulfonamide,5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-,monohydrochloride (...](https://img.guidechem.com/casimg/106463-17-6.gif) |
| Properties | |
| Solubility: | In water, 215.9 mg/L at 25 deg C (est) |
| Appearance: | White to Off-White Solid |
| Specification: |
?Tamsulosin hydrochloride , with CAS number of 106463-17-6, can be called (-)-(R)-5-(2-((2-(o-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide monohydrochloride ; Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, monohydrochloride, (R)- ; R-(-)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride ; Tamsulosin HCl . It is a?white to off-white solid, Tamsulosin hydrochloride (CAS NO.106463-17-6) extended-release tablets are marketed under the trade names Flomax, Flomaxtra and Urimax, though generic non-modified release capsules are still approved and marketed in many countries, such as Canada. The U.S. patent for Flomax is set to expire October 2009. |
| Usage: | Specific a1-adrenoceptor antagonist. Used in the treatment of benign prostatic hypertrophy |
| Safety Data | |
 |
|
